CAS 1092977-61-1

2-[[2-(3-Butoxyphenyl)ethyl]amino]-N,N-dimethylacetamide

Description:

2-[[2-(3-Butoxyphenyl)ethyl]amino]-N,N-dimethylacetamide, identified by its CAS number 1092977-61-1, is a chemical compound characterized by its amide functional group and a complex structure that includes both aromatic and aliphatic components. This substance features a butoxy group attached to a phenyl ring, contributing to its hydrophobic characteristics, while the dimethylacetamide portion enhances its solubility in organic solvents. The presence of the amino group suggests potential for hydrogen bonding, which may influence its reactivity and interaction with biological systems. Typically, compounds of this nature may exhibit properties such as moderate to high lipophilicity, making them suitable for applications in pharmaceuticals or as intermediates in organic synthesis. Additionally, the structural features may impart specific biological activities, although detailed studies would be necessary to elucidate its pharmacological profile. Overall, this compound represents a unique combination of functional groups that could be of interest in various chemical and medicinal chemistry applications.

Formula: C₁₆H₂₆N₂O₂

InChI: InChI=1S/C16H26N2O2/c1-4-5-11-20-15-8-6-7-14(12-15)9-10-17-13-16(19)18(2)3/h6-8,12,17H,4-5,9-11,13H2,1-3H3

InChI key: InChIKey=GRHBODILPPXVKN-UHFFFAOYSA-N

SMILES: C(CNCC(N(C)C)=O)C1=CC(OCCCC)=CC=C1

Synonyms:

• Evenamide
• 2-[[2-(3-Butoxyphenyl)ethyl]amino]-N,N-dimethylacetamide
• Acetamide, 2-[[2-(3-butoxyphenyl)ethyl]amino]-N,N-dimethyl-
• 2-((3-Butoxyphenethyl)amino)-N,N-dimethylacetamide
• N2-[2-(3-Butoxyphenyl)ethyl]-N,N-dimethylglycinamide
• psychosis,mania,voltage,Inhibitor,inhibit,gated,Na+ channels,Na channels,aggressiveness,schizophrenia,NW3509,channel,sodium,Sodium Channel,VGSC,depression,NW 3509,Evenamide
• NW-3509

Evenamide

CAS: 1092977-61-1

Evenamide

Purity: ≥95%

Molecular weight: 278.39g/mol

Ref: 54-BUP01388

Evenamide

CAS: 1092977-61-1

Evenamide (NW-3509) is a sodium channel blocker. Which shows efficacy in a broad spectrum of rodent models of psychosis, mania, depression, and aggressiveness.

Formula: C₁₆H₂₆N₂O₂

Purity: 96.74% - 99.15%

Color and Shape: Solid

Molecular weight: 278.39

Ref: TM-T15260

2-((3-BUTOXYPHENETHYL)AMINO)-N,N-DIMETHYLACETAMIDE

CAS: 1092977-61-1

Formula: C₁₆H₂₆N₂O₂

Purity: 95%

Molecular weight: 278.396

Ref: 10-F528576

Evenamide

CAS: 1092977-61-1

Evenamide is a pharmaceutical drug that is used in the treatment of Parkinson's disease. It is a potent and selective inhibitor of ectopic expression of trifluoromethyl-CoA reductase, which is an enzyme involved in the synthesis of fatty acids. This agent has also been shown to be effective against symptoms of schizophrenia. Evenamide was found to be statistically significant for treating symptoms in schizophrenic patients and has been shown to reduce hyperactivity and voltage-gated Na+ currents.

Formula: C₁₆H₂₆N₂O₂

Purity: Min. 95%

Molecular weight: 278.39 g/mol

Ref: 3D-STB97761